High TMB was associated with longer PFS in patients treated with only PD-L1 inhibitors (HR = 0.76, 95%CI: 0.57–1.02, P = 0.070), but the association did not reach statistical significance which may be due to substantial between-study heterogeneity.
← all excerpts
Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis.
1
—
—